Eosinophil Granulocytes, commonly referred to as eosinophils, are a specialized type of white blood cell belonging to the immune system. Named for their distinctive staining characteristics with eosin dye, these granulocytes play a crucial role in the body's defense against parasitic infections and modulating allergic reactions. Eosinophils are produced in the bone marrow and then migrate to various tissues, especially the gastrointestinal tract, respiratory system, and adipose tissue. They contain granules filled with diverse proteins, enzymes, and toxic substances that are released upon activation. Eosinophils actively participate in immune responses by targeting and neutralizing parasites through a process known as degranulation. Additionally, eosinophils contribute to the regulation of inflammation and immune balance. While their role in allergies is well-established, eosinophils are also implicated in autoimmune diseases and certain inflammatory conditions. Monitoring eosinophil counts in blood tests can provide insights into the body's immune status and help diagnose specific disorders. The interaction between eosinophils and other immune cells is complex, with ongoing research unraveling the intricate mechanisms underlying their functions. Despite their protective roles, excessive eosinophil activity can lead to tissue damage and contribute to pathological conditions, emphasizing the need for a balanced immune response.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy